NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ADC Development Panel, a specialized gene expression tool for use in the rapidly expanding field of Antibody Drug Conjugates (ADCs). Created in collaboration with leading pharmaceutical and clinical scientists, this novel panel is designed to provide molecular insights into important biological questions and challenges of oncology therapies.
What To Know About Biden-Backed ‘Blue’ Hydrogen And Why It Might Be A Worse Polluter Than Coal
A renewable energy resource hailed by President Joe Biden as being a tool in mitigating climate change might actually be worse for the environment than fossil fuels, according to a new scientific report published in the scientific journal Energy Science & Engineering.
